Intuitive Surgical, Inc. (ISRG) income statement
NASDAQ · Healthcare · Medical - Instruments & Supplies · 17,021 employees · CEO David J. Rosa
- Price
- $432.01 -3.73%
- Market cap
- $153B
- Enterprise value
- $150B
- Last report
- Q3 '26 filed 2026-10-21
- Next report
- 2027-01-28 EPS est. $2.97
Intuitive Surgical, Inc. (ISRG) reported revenue of $3.05B for Q3 '26 (+21.7% year on year), operating income of $593M (19.4% of revenue) and net income of $523M. Over the last four quarters revenue was $11.6B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.93B | $1.89B | $2.01B | $2.04B | $2.41B | $2.25B | $2.44B | $2.51B | $2.87B | $2.77B | $2.89B | $3.05B | |
| Cost of revenue | $651M | $645M | $637M | $664M | $771M | $796M | $822M | $843M | $962M | $940M | $932M | $964M | |
| Gross profit | $1.28B | $1.25B | $1.37B | $1.37B | $1.64B | $1.46B | $1.62B | $1.66B | $1.9B | $1.83B | $1.96B | $2.08B | |
| Research & development | $260M | $285M | $280M | $286M | $295M | $316M | $313M | $329M | $353M | $362M | $371M | $408M | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.08B | |
| Operating expenses | $827M | $776M | $805M | $797M | $907M | $880M | $875M | $903M | $1.04B | $975M | $989M | $1.49B | |
| Operating income | $450M | $469M | $567M | $577M | $735M | $578M | $743M | $760M | $864M | $855M | $972M | $593M | |
| Interest income | $65.7M | $69.1M | $87.2M | $93.7M | $74.9M | $90.4M | $88.7M | $95.5M | $91.3M | $85.1M | $85.1M | $75.8M | |
| Other non-operating income (gains on investments, FX ...) | -$65.7M | -$69.1M | -$87.2M | -$93.7M | -$74.9M | -$90.4M | -$88.7M | -$95.5M | -$91.3M | -$85.1M | -$2.4M | -$75.8M | |
| Total non-operating income | $65.7M | $69.1M | $87.2M | $93.7M | $74.9M | $90.4M | $88.7M | $95.5M | $91.3M | $85.1M | $82.7M | $75.8M | |
| Income before tax | $516M | $539M | $655M | $671M | $810M | $669M | $832M | $855M | $956M | $940M | $1.05B | $668M | |
| Income tax | -$94.8M | -$8.9M | $123M | $100M | $122M | -$35.2M | $168M | $146M | $156M | $114M | $231M | $144M | |
| Net income | $606M | $545M | $527M | $565M | $686M | $698M | $658M | $704M | $795M | $822M | $818M | $523M | |
| EPS (basic) | $1.72 | $1.54 | $1.48 | $1.59 | $1.92 | $1.95 | $1.84 | $1.98 | $2.24 | $2.31 | $2.32 | $1.50 | |
| EPS (diluted) | $1.69 | $1.51 | $1.46 | $1.56 | $1.88 | $1.92 | $1.81 | $1.95 | $2.21 | $2.28 | $2.35 | $1.49 | |
| Shares (basic, weighted) | 352M | 354M | 355M | 356M | 356M | 358M | 359M | 357M | 355M | 355M | 355M | 349M | |
| Shares (diluted, weighted) | 358M | 361M | 361M | 363M | 364M | 365M | 364M | 362M | 360M | 360M | 359M | 352M | |
| Depreciation & amortization | $123M | $109M | $112M | $116M | $125M | $141M | $155M | $160M | $221M | $200M | $231M | $0 | |
| EBITDA | $639M | $648M | $766M | $787M | $935M | $809M | $987M | $1.02B | $1.18B | $1.14B | $1.21B | $668M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.13B | $3.72B | $4.48B | $4.36B | $5.71B | $6.22B | $7.12B | $8.35B | $10.1B | |
| Cost of revenue | $814M | $935M | $1.12B | $1.37B | $1.5B | $1.75B | $2.03B | $2.39B | $2.72B | $3.42B | |
| Gross profit | $1.89B | $2.19B | $2.6B | $3.11B | $2.86B | $3.96B | $4.2B | $4.73B | $5.63B | $6.64B | |
| Research & development | $240M | $329M | $418M | $557M | $595M | $671M | $879M | $999M | $1.15B | $1.31B | |
| General & administrative | $705M | $811M | $987M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $945M | $1.14B | $1.4B | $1.74B | $1.81B | $2.14B | $2.62B | $2.96B | $3.29B | $3.7B | |
| Operating income | $945M | $1.05B | $1.2B | $1.37B | $1.05B | $1.82B | $1.58B | $1.77B | $2.35B | $2.95B | |
| Interest income | $35.6M | $41.9M | $80.1M | $128M | $157M | $69.3M | $29.7M | $192M | $325M | $366M | |
| Other non-operating income (gains on investments, FX ...) | -$4.5M | $0 | $0 | $0 | $0 | -$69.3M | -$29.7M | -$192M | -$325M | -$366M | |
| Total non-operating income | $35.6M | $41.9M | $80.1M | $128M | $157M | $69.3M | $29.7M | $192M | $325M | $366M | |
| Income before tax | $981M | $1.1B | $1.28B | $1.5B | $1.21B | $1.89B | $1.61B | $1.96B | $2.67B | $3.31B | |
| Income tax | $245M | $437M | $155M | $120M | $140M | $162M | $262M | $142M | $336M | $435M | |
| Net income | $736M | $660M | $1.13B | $1.38B | $1.06B | $1.7B | $1.32B | $1.8B | $2.32B | $2.86B | |
| EPS (basic) | $2.13 | $1.97 | $3.31 | $3.98 | $3.02 | $4.79 | $3.72 | $5.12 | $6.54 | $8.00 | |
| EPS (diluted) | $2.08 | $1.89 | $3.16 | $3.85 | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 | |
| Shares (basic, weighted) | 345M | 335M | 341M | 346M | 351M | 356M | 356M | 351M | 355M | 357M | |
| Shares (diluted, weighted) | 354M | 349M | 356M | 359M | 361M | 366M | 362M | 357M | 362M | 363M | |
| Depreciation & amortization | $92.1M | $99.1M | $123M | $203M | $276M | $310M | $366M | $455M | $462M | $677M | |
| EBITDA | $1.04B | $1.16B | $1.32B | $1.58B | $1.33B | $2.2B | $1.97B | $2.41B | $3.14B | $3.99B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01